Investigational Drug Information for Nepadutant
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Nepadutant?
Nepadutant is an investigational drug.
There have been 4 clinical trials for Nepadutant.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Colic, Digestive System Diseases, and Gastrointestinal Diseases. The leading clinical trial sponsors are Menarini Group and [disabled in preview].
Summary for Nepadutant
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 10 |
WIPO Patent Applications | 4 |
Japanese Patent Applications | 0 |
Clinical Trial Progress | Phase 2 (2010-11-01) |
Vendors | 6 |
Recent Clinical Trials for Nepadutant
Title | Sponsor | Phase |
---|---|---|
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance | Menarini Group | Phase 2 |
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment | Menarini Group | Phase 2 |
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic | Menarini Group | Phase 2 |
Clinical Trial Summary for Nepadutant
Top disease conditions for Nepadutant
Top clinical trial sponsors for Nepadutant
US Patents for Nepadutant
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |